3
Scheme 5. Selective reduction of cyclopenta[c]pyridines 3a,c.
In conclusion, during the course of this investigation the
reaction between 2-azanorbornenes and activated alkynes was
carried out. The obtained results revealed that the reaction
proceeds via the stereoselective amino-Claisen rearrangement.
This simple protocol may be useful in the synthesis of natural-
like products possessing a cyclopenta[c]pyridine core.
Figure 2. Crystal structure for compound 3m. Displacement
ellipsoids are shown at the 50% probability level. Almost all H
atoms of the molecule were deleted for clarity, H-4a, H-5, H-6 and
H-7a atoms are shown as small spheres of arbitrary radii.
Acknowledgments
This publication was supported by the Ministry of Education
and Science of the Russian Federation (the Agreement number
02.a03.21.0008).
The single crystal X-ray structure of di-tert-butyl ester 3m (R1
= Me, R2 = t-Bu) is shown in Figure 2. Compound 3m comprises
of the fused bicyclic system containing five-membered
(cyclopentene) and six-membered (piperidine) rings. The five-
membered ring possess a flat envelope conformation, and the six-
membered ring adopts a distorted flat boat conformation. The
nitrogen atom is almost planar (sum of the bond angles are
356.9°). The dihedral angle between H-4a and H-7a is 31.5(6)°.
References and notes
1. Eisenbraun, E. J.; Sullins, D. W.; Browne, C. E.; Shooler, J. N. J. Org.
Chem. 1988, 53, 3968.
2. Saad, H. E. A.; Anton, R.; Quirion, J. C.; Chauviere, G.; Pusset, J.
Tetrahedron Lett. 1988, 29, 615.
3. Skaltsounis, A. L.; Michel, S.; Tillequin, F.; Koch, M. Tetrahedron Lett.
1984, 25, 2783.
4. Pombo-Villar, E.; Boelsterli, J.; Cid, M. M.; France, J.; Fuchs, B.;
Walkinshaw, M.; Weber, H. P. Helv. Chim. Acta 1993, 76, 1203.
5. (a) Stefanska, A. L.; Cassels, R.; Ready, S. J.; Warr, S. R. J. Antibiot.
2000, 53, 357. (b) Houge-Frydrych, C. S. V.; Gilpin, M. L.; Skett, P. W.;
Tyler, J. W. J. Antibiot. 2000, 53, 364.
6. (a) Takahashi, A.; Naganawa, H.; Ikeda, D.; Okami, Y. Tetrahedron
1991, 47, 3621. (b) Kende, A. S.; Lui, K.; Brands, K. M. J. J. Am. Chem.
Soc. 1995, 117, 10597. (c) Banwell, M. G.; Crasto, C. F.; Easton, C. J.;
Forrest, A. K.; Karoli, T.; March, D. R.; Mensah, L.; Nairn, M. R.;
O'Hanlon, P. J.; Oldham, M. D.; Yue, W. Bioorg. Med. Chem. Lett. 2000,
10, 2263.
In order to synthesize structures more closely related to
altemicidin and SB-203207, we demonstrated that propiolamide
(PA)12 can also be involved in the rearrangement (Scheme 4).
7. Hirooka, Y.; Ikeuchi, K.; Kawamoto, Y.; Akao, Y.; Furuta, T.; Asakawa,
T.; Inai, M.; Wakimoto, T.; Fukuyama, T.; Kan, T. Org. Lett. 2014, 16,
1646.
8. (a) Larsen, S. D.; Grieco, P. A. J. Am. Chem. Soc. 1985, 107, 1768. (b)
Grieco, P. A.; Larsen, S. D. Org. Synth. 1990, 68, 206. (c) Demuynck, A.
L. W.; Levecque, P.; Kidane, A.; Gammon, D. W.; Sickle, E.; Jacobs, P.
A.; De Vos, D. E.; Sels, B. F. Adv. Synth. Catal. 2010, 352, 3419. (d)
Memeo, M. G.; Mantione, D.; Bovio, B.; Quadrelli, P. Synthesis 2011,
13, 2165. (e) Gorbunova, M.; Anikina, L. Eur. J. Med. Chem. 2013, 63,
655.
9. (a) Alonso, D. A.; Bertilsson, S. K.; Johnsson, S. Y.; Nordin, S. J. M.;
Soedergren, M. J.; Andersson, P. G. J. Org. Chem. 1999, 64, 2276. (b)
Malpass, J. R.; White, R. J. Org. Chem. 2004, 69, 5328. (c)
Venkatraman, S.; Njoroge, F. G.; Wu, W.; Girijavallabhan, V.; Prongay,
A. J.; Butkiewicz, N.; Pichardo, J. Bioorg. Med. Chem. Lett. 2006, 16,
1628. (d) Bunnelle, W. H.; Daanen, J. F.; Ryther, K. B.; Schrimpf, M. R.;
Dart, M. J.; Gelain, A.; Meyer, M. D.; Frost, J. M.; Anderson, D. J.;
Buckley, M.; Curzon, P.; Cao, Y.-J.; Puttfarcken, P.; Searle, X.; Ji, A.;
Putman, C. B.; Surowy, C.; Toma, L.; Barlocco, D. J. Med. Chem. 2007,
50, 3627. (e) Mazurov, A. A.; Miao, L.; Bhatti, B. S.; Strachan, J.-P.;
Akireddy, S.; Murthy, S.; Kombo, D.; Xiao, Y.-D.; Hammond, P.;
Zhang, J.; Hauser, T. A.; Jordan, K. G.; Miller, C. H.; Speake, J. D.;
Gatto, G. J.; Yohannes, D. J. Med. Chem. 2012, 55, 9181. (f) Potter, R.
A.; Bowser, A. M.; Yang, Y.; Madalengoitia, J. S.; Ziller, J. W. J. Org.
Chem. 2013, 78, 11772.
Scheme 4. Amino-Claisen rearrangement of 2-azanorbornenes (1)
under the action of propiolamide.
Amides 4a and 4b were isolated in moderate yields. In the
case of R1 = Me, a compound resembling the A ring of SB-
203207 (Fig. 1) was generated in one step.
We also attempted to perform further modifications of the
unsubstituted double bond in cyclopenta[c]pyridines 2-4, in order
to develop routes to access the target natural products.
Unfortunately, the Prilezhaev oxidation of compounds 2a, 3a,
and 4a with m-CPBA did not occur over a broad temperature
range (0–70 °C), and instead of the desired epoxides a
multicomponent mixture formed. However, the reduction of
cyclopenta[c]pyridines (3) proceeded chemospecifically at the
least substituted and more electronically enriched double bond of
the five-membered ring, leading to derivatives 5, possessing the
core of nepetalactam and lindenialine, in good yields (Scheme 5).
10. (a) Gayet, A.; Andersson, P. G. Synth. Catal. 2005, 347, 1242. (b)
Pombo-Villar, E.; Boelsterli, J.; Cid, M. M.; France, J.; Fuchs, B.;
Walkinshaw, M.; Weber, H. P. Helv. Chim. Acta. 1993, 76, 1203.
11. (a) Baxter, E. W.; Labaree, D.; Chao, S.; Mariano, P. S. J. Org. Chem.
1989, 54, 2893. (b) Baxter, E. W.; Labaree, D.; Ammon, H. L.; Mariano,
P. S. J. Am. Chem. Soc. 1990, 112, 7682.
12. Hay, L. A.; Koenig, T. M.; Ginah, F. O.; Copp, J. D.; Mitchell, D. J. Org.
Chem. 1998, 63, 5050.